| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 21,540 | 24,469 | 21,021 | 23,380 | | Cost of Revenue | 24,099 | 3,775 | 3,628 | 3,515 | | | Gross Profit | (2,558) | 20,694 | 17,393 | 19,865 | | | Operating Expenses | | Research Development | (13,056) | 6,748 | 6,308 | 6,937 | | Selling General and Administrative | 12,781 | 13,507 | 11,732 | 13,087 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 180 | 180 | 178 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,464) | 259 | (825) | (159) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (221) |
-
| 454 | | Earnings Before Interest And Taxes | (2,224) | 39 | (825) | 295 | | Interest Expense |
-
| (453) | 453 |
-
| | Income Before Tax | (2,224) | 492 | (1,279) | 295 | | Income Tax Expense | (193) | (775) | (428) | (343) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,031) | 1,267 | (851) | 638 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,031) | 1,267 | (851) | 638 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,031) | $1,267 | ($851) | $638 |
|
0.02% Nasdaq 
Income Statement
